Generic method for latex agglutination assays
View Patent ↗An improved agglutination immunoassay is characterized by reacting a sample fluid which may contain an analyte with a generic antibody conjugated to latex particles and then adding an antibody specific to the analyte to be determined. Agglutination resulting from adding the antibody specific to the analyte is measured and correlated with the amount of analyte in the sample.
1. A system for determining the presence of an analyte in a sample by agglutination of particles consisting essentially of:
(a) a first reagent comprising of a non-specific antibody to Ig antibodies conjugated to latex particles;
(b) a second reagent comprising of an antibody specific to said analyte, which reagent is capable of causing agglutination of the latex particles of (a) when said first and second reagents are combined, said non-specific antibody binding at the Fc portion of said antibody specific to said analyte;
(c) a means for measuring the amount of light at a predetermined wavelength absorbed by agglutination of said latex particles of (a) when said first and second reagents are combined with said sample, thereby determining the presence of an analyte in said sample and permitting correlation of the degree of said agglutination in inverse proportion to the amount of said analyte in said sample.
2. The system of claim 1 wherein said antibody specific to said analyte is an antibody to deoxypyridinoline (Dpd).
3. The system of claim 1 wherein said antibody specific to said analyte is an antibody to digoxin.
4. The system of claim 1 wherein said antibody specific to said analyte is an antibody to theophylline.
5. The system of claim 1 wherein said non-specific antibody is an antibody to mouse IgG.
6. The system of claim 5 wherein said non-specific antibody is the Fc portion of mouse IgG.
7. The system of claim 5 wherein said antibody to mouse IgG is derived from rabbits.
8. The system of claim 5 wherein said antibody to mouse IgG is derived from goats.
9. The system of claim 1 wherein said antibody specific to said analyte is a monoclonal antibody.